ABSTRACT
Background: This report presents the influence of immunosuppression by new rheumatological therapies on hepatitis E virus infection in a 54-year-old male patient with an anti-synthetase syndrome and treatment with methotrexate and rituximab. Case description: The patient arrived at the Emergency Department with epigastric pain, vomiting and dark urine. Initial examination revealed signs of inflammation and hepatic dysfunction. Subsequent laboratory tests and imaging confirmed acute hepatitis E infection in the context of recent initiation of rituximab therapy. Despite initial suspicion of pancreatitis, subsequent investigations ruled out pancreatic involvement. Treatment with ribavirin, along with supportive measures, led to significant clinical improvement with resolution of jaundice, ascites, and oedema. Conclusions: This case underscores the importance of considering hepatitis E in patients with autoimmune conditions, especially when initiating immunosuppressive therapies, a situation that is not well described in scientific literature and is increasingly common, necessitating proper recognition. LEARNING POINTS: Suspect hepatitis E virus infection in the presence of persistent liver failure of unknown cause.Recognise immunosuppression as a cause of increased risk of hepatitis E infection.Take into account the repercussions of immunosuppressive therapy such as rituximab regarding hepatitis E infections in immunocompromised patients.
ABSTRACT
BACKGROUND: EUS-guided cholangiopancreatography (ESCP) allows transmural access to biliopancreatic ducts when ERCP fails. Data regarding technical details, safety, and outcomes of ESCP are still unknown. OBJECTIVE: To evaluate outcomes of ESCP in community and referral centers at the initial development phase of this procedure, to identify the ESCP stages with higher risk of failure, and to evaluate the influence on outcomes of factors related to the endoscopist. DESIGN: Multicenter retrospective study. SETTING: Public health system hospitals with experience in ESCP in Spain. PATIENTS: A total of 125 patients underwent ESCP in 19 hospitals, with an experience of <20 procedures. INTERVENTION: ESCP. MAIN OUTCOME MEASUREMENTS: Technical success and complication rates in the initial phase of implantation of ESCP are described. The influence of technical characteristics and endoscopist features on outcomes was analyzed. RESULTS: A total of 125 patients from 19 hospitals were included. Biliary ESCP was performed in 106 patients and pancreatic ESCP was performed in 19. Technical success was achieved in 84 patients (67.2%) followed by clinical success in 79 (63.2%). Complications occurred in 29 patients (23.2%). Unsuccessful manipulation of the guidewire was responsible for 68.2% of technical failures, and 58.6% of complications were related to problems with the transmural fistula. LIMITATIONS: Retrospective study. CONCLUSION: Outcomes of ESCP during its implantation stage reached a technical success rate of 67.2%, with a complication rate of 23.2%. Intraductal manipulation of the guidewire seems to be the most difficult stage of the procedure.
Subject(s)
Biliary Tract Diseases/therapy , Cholangiography/methods , Drainage/methods , Endoscopy, Digestive System/methods , Endosonography , Pancreatic Diseases/therapy , Ultrasonography, Interventional , Aged , Aged, 80 and over , Biliary Tract Diseases/diagnostic imaging , Drainage/instrumentation , Female , Health Care Surveys , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Pancreatic Diseases/diagnostic imaging , Pancreatic Ducts/diagnostic imaging , Retrospective Studies , Spain , Stents , Treatment OutcomeSubject(s)
Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Endoscopes , Hematoma/etiology , Liver Diseases/etiology , Liver/blood supply , Postoperative Hemorrhage/etiology , Sphincterotomy, Endoscopic/adverse effects , Aged , Antibiotic Prophylaxis , Blood Vessels/injuries , Cholangiopancreatography, Endoscopic Retrograde/instrumentation , Choledocholithiasis/surgery , Equipment Design , Female , Hematoma/diagnostic imaging , Humans , Hydrophobic and Hydrophilic Interactions , Liver/diagnostic imaging , Liver Diseases/diagnostic imaging , Postoperative Hemorrhage/diagnostic imaging , Rupture/etiology , Tomography, X-Ray ComputedABSTRACT
No disponible
